Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized Budesonide Combined With Systemic Corticosteroid in Acute Severe Asthma
NCT04016220Phase 1Unknown
- Sponsor
- Université de Monastir
- Start
- May 2019
- Primary completion
- Dec 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of budesonide (2 arms), sponsored by Université de Monastir. Primary endpoint: Admission rate at 3 hours. Status: unknown.
02
Drugs
budesonide
Beyond the preview
Go deeper on NCT04016220.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04016220.